Sign In
Buy ISEE
$39.95
+0 (+0%)
At Close: Oct 09, 2023
Iveric Bio to Present at Upcoming Investor Conferences
04:30pm, Friday, 04'th Nov 2022
PARSIPPANY, N.J.
Apellis Pharma Crashes On Unexpected Delay For Eye Drug — A Boon For Iveric Bio
10:06am, Friday, 04'th Nov 2022
Apellis reported an unexpected delay for its eye-disease treatment, leading APLS stock to crash as shares of rival Iveric Bio inched higher. The post Apellis Pharma Crashes On Unexpected Delay For Eye
Iveric Bio Reports Third Quarter 2022 Operational Highlights and Financial Results
06:30am, Thursday, 03'rd Nov 2022
PARSIPPANY, N.J.--(BUSINESS WIRE)--IVERIC bio, Inc. (Nasdaq: ISEE) today announced financial and operating results for the third quarter ended September 30, 2022 and provided a general business update
These Were The Five Best And Worst Performing Mid-Cap Stocks In September 2022
07:41pm, Monday, 17'th Oct 2022
Mid-cap stocks are a good choice for investors who are okay with relatively more volatility to get some extra returns.
PARSIPPANY, N.J.--(BUSINESS WIRE)--Iveric Bio will present top-line efficacy and safety results from GATHER2, the Company's second Phase 3 clinical trial of Zimura, at AAO 2022.
IVERIC bio (ISEE) Posts Positive Top-Line Data From GA Study
03:03pm, Wednesday, 07'th Sep 2022
IVERIC bio (ISEE) reports positive top-line data from the phase III GATHER2 study, evaluating its investigational candidate, Zimura, for the treatment of geographic atrophy. Stock up.
Iveric bio: Further Upside Possible Based On Expanded Opportunities With Zimura
06:23am, Wednesday, 07'th Sep 2022
Positive results achieved in both GATHER1 and GATHER2 studies, whereby Zimura met prespecified primary endpoints of Mean rate of GA growth compared to sham control with statistical significance. NDA f
Why Is Iveric Bio (ISEE) Stock Up 56% Today?
11:43am, Tuesday, 06'th Sep 2022
Source: Shutterstock / PopTika Iveric Bio (NASDAQ: ISEE ) stock is rising higher on Tuesday after the biopharmaceutical company revealed positive results from a Phase 3 clinical trial. That trial cove
7 Cheap Biotech Stocks to Buy Now
04:42pm, Wednesday, 03'rd Aug 2022
Biopharmaceutical companies have been struggling since 2021 and that narrative isn't immediately changing. However, not every firm deserves this fate.
Benzinga's Top Ratings Upgrades, Downgrades For August 2, 2022
02:20pm, Tuesday, 02'nd Aug 2022 Benzinga
Upgrades
For Transocean Ltd (NYSE:RIG), Capital One upgraded the previous rating of Equal-Weight to Overweight. Transocean earned $0.10 in the second quarter, compared to $0.18 in the year-ago quarter
What 5 Analyst Ratings Have To Say About IVERIC bio
12:47pm, Tuesday, 02'nd Aug 2022 Benzinga
Within the last quarter, IVERIC bio (NASDAQ:ISEE) has observed the following analyst ratings:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
3
1
1
0
0
Last 30D
3 Biotech Stock Picks From This Wedbush Analyst
09:27pm, Wednesday, 27'th Jul 2022 Benzinga
While the S&P 500 index peaked in January and has had a rough year, the biotech sector peaked last August. For the time being, both have found a short-term and possible long-term bottom in June.
Dav
IVERIC bio, Inc. (ISEE) Q2 2022 Earnings Call Transcript
04:00pm, Tuesday, 26'th Jul 2022 The Motley Fool
ISEE earnings call for the period ending June 30, 2022.
IVERIC bio, Inc. (ISEE) CEO Glenn Sblendorio on Q2 2022 Results - Earnings Call Transcript
02:09pm, Tuesday, 26'th Jul 2022
IVERIC bio, Inc. (NASDAQ:ISEE ) Q2 2022 Earnings Conference Call July 26, 2022 8:00 AM ET Company Participants Kathy Galante - SVP of IR Glenn Sblendorio - CEO Pravin Dugel - President Keith Westby -
Alibaba, General Electric And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
11:35am, Tuesday, 26'th Jul 2022 Benzinga
Redbox Entertainment Inc. (NASDAQ: RDBX) rose 11.5% to $6.19 in pre-market trading after jumping 82% on Monday.
Shell Midstream Partners, L.P. (NYSE: SHLX) rose 9.3% to $15.90 in pre-market trading.
